These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25364356)

  • 1. D-cycloserine for treatment of numbing and avoidance in chronic post traumatic stress disorder: A randomized, double blind, clinical trial.
    Attari A; Rajabi F; Maracy MR
    J Res Med Sci; 2014 Jul; 19(7):592-8. PubMed ID: 25364356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD.
    Yeh MS; Mari JJ; Costa MC; Andreoli SB; Bressan RA; Mello MF
    CNS Neurosci Ther; 2011 Oct; 17(5):305-10. PubMed ID: 21554564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
    Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
    Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
    Scheeringa MS; Weems CF
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing emotional numbing symptoms of posttraumatic stress disorder from major depressive disorder.
    Duek O; Seidemann R; Pietrzak RH; Harpaz-Rotem I
    J Affect Disord; 2023 Mar; 324():294-299. PubMed ID: 36586605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of group mindfulness-based cognitive therapy (MBCT) for combat veterans with posttraumatic stress disorder (PTSD).
    King AP; Erickson TM; Giardino ND; Favorite T; Rauch SA; Robinson E; Kulkarni M; Liberzon I
    Depress Anxiety; 2013 Jul; 30(7):638-45. PubMed ID: 23596092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder.
    Heresco-Levy U; Kremer I; Javitt DC; Goichman R; Reshef A; Blanaru M; Cohen T
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):301-7. PubMed ID: 12466030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requiring both avoidance and emotional numbing in DSM-V PTSD: will it help?
    Forbes D; Fletcher S; Lockwood E; O'Donnell M; Creamer M; Bryant RA; McFarlane A; Silove D
    J Affect Disord; 2011 May; 130(3):483-6. PubMed ID: 21071095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
    Zisook S; Chentsova-Dutton YE; Smith-Vaniz A; Kline NA; Ellenor GL; Kodsi AB; Gillin JC
    J Clin Psychiatry; 2000 Mar; 61(3):203-8. PubMed ID: 10817106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
    Feder A; Costi S; Rutter SB; Collins AB; Govindarajulu U; Jha MK; Horn SR; Kautz M; Corniquel M; Collins KA; Bevilacqua L; Glasgow AM; Brallier J; Pietrzak RH; Murrough JW; Charney DS
    Am J Psychiatry; 2021 Feb; 178(2):193-202. PubMed ID: 33397139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of posttraumatic stress disorder and extinction learning of traumatic memory].
    Asukai N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Jun; 33(3):111-5. PubMed ID: 25069244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD.
    Yamamoto S; Morinobu S; Fuchikami M; Kurata A; Kozuru T; Yamawaki S
    Neuropsychopharmacology; 2008 Aug; 33(9):2108-16. PubMed ID: 17957211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
    Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label assessment of aripiprazole in the treatment of PTSD.
    Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG
    Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol.
    Maier A; Dharan A; Oliver G; Berk M; Redston S; Back SE; Kalivas P; Ng C; Kanaan RA
    BMC Psychiatry; 2020 Aug; 20(1):397. PubMed ID: 32762663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
    de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
    J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PTSD symptom groups with functional impairment and distress in trauma-exposed disaster survivors.
    North CS; Van Enkevort E; Hong BA; Surís AM
    Psychol Med; 2020 Jul; 50(9):1556-1562. PubMed ID: 31258106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divalproex in posttraumatic stress disorder: an open-label clinical trial.
    Clark RD; Cañive JM; Calais LA; Qualls CR; Tuason VB
    J Trauma Stress; 1999 Apr; 12(2):395-401. PubMed ID: 10378177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.